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Abstract 
An efficient ring rearrangement metathesis (RRM) approach to the synthesis of benzo[b]quinolizine and 
benzoindolizine systems from N-propargyl-phenanthridine derivatives is reported. A novel use of flash 
vacuum pyrolysis (FVP) for the Boc-deprotection of acid sensitive substrates is also disclosed. 
 
Introduction 
Domino metathesis or ring-rearrangement metathesis reactions (RRM), employing combinations of 
RCM, ROM and cross-metathesis protocols have been developed recently,1 and successfully applied to 
complex molecule synthesis.2 These RRM reactions involve intramolecular metathesis of a substrate 1 
containing an endocyclic olefin and a tethered exocyclic alkene or alkyne bond, to afford product 2 (e.g. 
Scheme 1).3 The reactions are conducted using a Grubbs metathesis catalyst under an ethylene 
atmosphere. 
 
1 2
RRM
Grubbs cat.
CH2=CH2 (g)
 
Scheme 1. Ring Rearrangement Metathesis of a Cycloalkene-yne substrate.3 Reagents and Conditions: 
a) Grubbs Metathesis catalyst (15 mol%), ethylene, CH2Cl2. 
 
We recently disclosed novel methodology for the rapid and efficient synthesis of cis-ring fused 
phenanthridine double bond isomers 4a (1,2 alkene), 4b (2,3) and 4c (3,4) in excellent yield using the 
Heck reaction (Scheme 2).4 The phenanthridine core lies at the heart of many bioactive natural products 
including the antitumour antibiotic pancratistatin,5 antiviral lycorine,6 and the tubulin polymerisation 
inhibitor chelidonine.7 As part of our ongoing efforts towards the synthesis of a small library of natural-
product-like analogues derived from this interesting core structure,8 we have investigated the 
application of an cycloalkene-yne RRM protocol to N-propargyl derivatives (5a-c) of these alkene 
isomers. We realised, that if successful, this would give access to three skeletally diverse products (6 
[6,6,7], 7 [6,6,6], 8 [6,6,5]) using a common metathesis process (Scheme 3). 
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Scheme 2. Heck cyclisation approach to the phenanthridine core.4           P = Boc, Cbz, SO2Me. 4a=
1,2; 
4b=2,3; 4c=3,4. Reagents and Conditions: Herrmann-Beller palladacycle (5 mol%), MeNCy2, DMF, 
140 oC; or Pd2(dba)3, 
tBu3PHBF4 (10 mol%), MeNCy2, MeCN, r.t.50 
oC. 
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Scheme 3. Proposed RRM of the phenanthridine double-bond isomers. 5a=1,2; 5b=2,3; 5c= 3,4. 
 
Two significant obstacles to the RRM reactions of substrates 5a-c were envisaged. Firstly, application 
of RRM reactions to nitrogen-containing systems are hindered by coordination of the amino group to 
the transition metal of the metathesis catalyst, leading to deactivation and poor reactivity.9 Successful 
approaches to counteracting this problem include the use of Lewis acids;10 amines with strongly 
electron-withdrawing functionality (such as sulfonamides11,12 or carbamates);12 and ammonium salts.13 
Secondly, highly strained cycloalkenes such as norbornene,12,14 cyclobutene,15 and cyclopentene3,15,16 are 
typically used in RRM reactions so that the ring-opening step is strongly favoured and higher 
conversions are obtained. There are only a few examples of the use of unstrained cycloalkene-yne 
substrates in RRM reactions and these tend to proceed in only low to moderate yields.3,11,13,17 Herein, we 
report the mild and efficient RRM of unstrained N-propargyl phenanthridines 5a-c to afford skeletally 
diverse products. To the best of our knowledge, this represents the first example of the use of an 
unstrained and natural-product-like aminocycloalkene-yne for such a purpose. 
In order to access the desired N-propargyl phenanthridine double bond isomers 5a-c, we first examined 
the application of our Heck methodology to an N-propargyl derivative of precursor 3 (P = CH2CCH). 
However, we found that the substrate was not compatible with either of the Heck cyclisation protocols 
we had developed in our previous work.4 As a result we examined direct deprotection of the isolated 
Boc-phenanthridine double bond isomers 4a-c, followed by N-propargylation (Table 1). 
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NH
H
H
NBoc
H
H
4a-c 9a-c  
Entry Substrate Conditions t (h) Conversion 
 (%)a 
1 4a TFA, CH2Cl2, r.t. 0.5 100 
b
 
2 4a TFA, CH2Cl2, 0 
oC 1 100 b 
3 4a ZnBr2 (2.7 eq), CH2Cl2, r.t. 16 100
 b
 
4 4a SnCl4 (4 eq), EtOAc, r.t.  16 n.d. 
5 4a CAN (0.2 eq), MeCN, 80 
oC 16 n.d. 
6 4a TBAF (10 eq), THF, 80 
oC 16 n.d. 
7 4a Na2CO3, DME/H2O, 80 
oC 72 0 
8 4a FVP, 600 
oC 0.5 60 
9 4b FVP, 600 
oC 0.5 81 
10 4c FVP, 600 
oC 0.5 71 
a
 Determined by 1H NMR.  
b 
Significant double-bond isomerism observed.  
Table 1. Boc deprotection of phenanthridines 4a-c. 
 
Boc-deprotection proved to be less trivial than anticipated since application of standard acidic 
conditions (TFA/CH2Cl2) to the 
1,2 substrate 4a led to both deprotection and undesired isomerism of 
the double bond (Table 1, entries 1 & 2). Since this would prevent testing of the RRM reaction on 
isolated double bond isomers a range of alternative deprotection conditions were examined using the 
1,2 alkene isomer 4a, as illustrated in Table 1. These included Lewis acid catalysis (entries 3 & 4);18,19 
ceric ammonium nitrate (CAN) promoted oxidative radical cleavage (entry 5);20  TBAF (entry 6);21 and 
Na2CO3 (entry 7).
22 Unfortunately, none of these proved suitable, affording either deprotection with 
concomitant alkene isomerism (entries 1-3), or a mixture of unidentifiable products (entries 4-7). 
Finally we examined the use of flash vacuum pyrolysis (FVP)23 as this has been reported to faciliate 
Boc-deprotection in some cases.24 We were delighted to observe that exposure of 1,2 alkene 4a to the 
pyrolysis tube at 600 oC under vacuum (entry 8), led to the immediate and clean removal of the Boc-
group with no trace of double-bond isomerism. Gratifyingly, the deprotection conditions proved to be 
effective for all our alkene substrates, leading to the recovery of all three desired amines 9a-c in good 
yield (60-81%). These were then readily converted to the corresponding N-propargyl derivatives 5a-c 
using propargyl bromide and K2CO3 at 60 
oC in acetone in good yield (57-75%).  
With the N-propargyl-phenanthridines 5a-c in hand, we set about investigating the RRM reaction using 
Hoveyda-Grubbs II25 as the metathesis catalyst, since its use had precedence in ROM-polymerisation 
reactions.26 In order to prevent chelation of the amine to the Ru of the metathesis catalyst, we first 
Page 4 of 13 
converted the N-propargyl phenanthridine substrates 5a-c to the corresponding amine hydrochlorides 
using HCl in Et2O. We chose to study the RRM reaction of 
2,3 N-propargyl phenanthridine 5b first, as 
this potentially afforded the most conformationally favourable product, a [6,6,6]-ring annulated 
benzo[b]quinolizine 7. We were delighted to observe that application of the RRM conditions to this 
substrate led to formation of benzo[b]quinolizine 7 in excellent yield (Scheme 4). 
 
N
H
H
5b
a), b)
N
HH
7  
Scheme 4. Reagents and Conditions a) HCl in Et2O (2 eq); b) Hoveyda-Grubbs II (15 mol%), ethylene, 
CH2Cl2, r.t., 40 h, 71%. 
 
Following the success of this result, we applied these conditions to the other N-propargyl 
phenanthridine substrates 5a and 5c. Disappointingly, we observed quantitative recovery of the starting 
material upon the attempted RRM of 1,2 N-propargyl phenanthridine 5a. Performing the reaction at 
elevated temperature or with the less bulky Grubbs I catalyst had no impact on the outcome. However, 
we were pleased to discover that application of the Hoveyda-Grubbs II catalyst to the 3,4 N-propargyl-
phenanthridine 5c under an ethylene atmosphere gave complete conversion to the benzoindolizine 
product 8 (Scheme 5) in good yield. 
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Scheme 5. Reagents and Conditions a) HCl in Et2O (2 eq); b) Hoveyda-Grubbs II (15 mol%), ethylene, 
CH2Cl2, r.t., 40 h, 80%. 
 
In summary, we have illustrated a mild and efficient approach to the synthesis of benzo[b]quinolizine 
and benzoindolizine architectures 7 and 8 from unstrained aminocycloalkene-yne substrates using RRM 
Page 5 of 13 
methodology. In the course of our investigations we have also illustrated a novel use of FVP for the 
Boc-deprotection of substrates that are susceptible to undesired acid-catalysed alkene isomerism.  
 
General procedure for the FVP-preparation of phenanthridines 9a-c: Boc-protected phenanthridine 
4 (3 mmol) was treated to FVP conditions23 [Inlet T 140 oC, Furnace T 600 oC, P 3.2 x 10-2 Torr] for 30 
mins. The crude product was purified by Kugelrohr distillation (70 oC, 0.7 Torr) to afford the desired 
amine 9 as a yellow oil. 
General procedure for the preparation of N-propargyl phenanthridines 5a-c: To a solution of the 
appropriate phenanthridine 9 (1 mmol) in acetone (5 ml) was added anhydrous K2CO3 (3 mmol) and 
propargyl bromide (1.1 mmol). The reaction was heated at 60 oC for 2 h and then concentrated under 
reduced pressure. The crude product was purified by flash chromatography (CH2Cl2) to the desired 
propargyl amine 5 as a yellow oil. 
(11SR,11aSR)-11-Allyl-3-vinyl-1,6,11,11a-tetrahydro-4H-pyrido[1,2-b]isoquinoline 7: To a solution 
of propargyl amine 5b (50 mg, 0.22 mmol) in CH2Cl2 (1 ml) was added HCl (2 ml, 1 M in Et2O) and 
the solvent was removed under reduced pressure.  The resultant beige solid was dissolved in CH2Cl2 (10 
ml) and degassed with ethylene for 10 mins. Hoveyda-Grubbs II catalyst25 (21 mg, 33.6 µmol) was 
added and the reaction stirred under an atmosphere of ethylene for 40 h at r.t. The crude product was 
washed with NaOH (3 x 20 ml, 1 M aq.) and the combined organics dried (MgSO4), concentrated under 
reduced pressure and purified by flash chromatography (CH2Cl2:MeOH, 100:0-100:1) to afford 
benzo[b]quinolizine 7 as a colourless oil (40 mg, 71%). 
υmax (CHCl3)/cm
-1 2925, 1655, 1636; 1H NMR δ (360 MHz, CDCl3) 7.33 (1H, d, Ј 6.6), 7.18-7.14 (2H, 
m), 7.04-7.02 (1H, m), 6.34 (1H, dd, Ј 17.8, 10.9), 6.00-5.88 (1H, dddd,  Ј 17.1, 10.3, 8.4, 5.6), 5.86-
5.82 (1H, m), 5.16 (1H, dq, Ј 17.1, 1.2), 5.12 (1H, br d, Ј 10.3), 5.06 (1H, d, Ј 17.8), 4.97 (1H, d, Ј 
10.9), 4.07 (1H, d, Ј 15.8), 3.78 (1H, d, Ј 15.8), 3.77 (1H, d, Ј 17.0), 3.46 (1H, d, Ј 17.0), 3.34-3.30 
(2H, m), 2.91-2.84 (1H, m), 2.19-2.10 (1H, m), 2.06-1.94 (2H, m); 13C NMR δ (90.6 MHz, CDCl3) 
137.6 (CH), 136.8 (CH), 135.6 (C), 134.4 (C), 131.8 (C), 126.9 (CH), 126.3 (CH), 126.2 (CH), 126.0 
(CH), 125.7 (CH), 116.4 (CH2), 110.6 (CH2), 53.8 (CH), 52.3 (CH2), 50.0 (CH2), 40.6 (CH), 34.2 (CH2), 
20.1 (CH2); m/z (ESI+) 252 ([M+H]
+, 98 %), 211 (15), 172 (100), 145 (8), 131 (100); HRMS (EI) 
Found: [M]+, 251.1675. C18H21N requires 251.1669.  
(10SR,10aSR)-10-(But-3’-enyl)-2-vinyl-3,5,10,10a-tetrahydro-pyrrolo[1,2-b]isoquinoline 8: To a 
solution of propargyl amine 5c (10 mg, 45 µmol) in CH2Cl2 (1 ml) was added HCl (2 ml, 1 M in Et2O) 
and the solvent was removed under reduced pressure. The resultant beige solid was dissolved in CH2Cl2 
(10 ml) and degassed with ethylene for 10 mins. Hoveyda-Grubbs II catalyst25 (4.2 mg, 6.7 µmol) was 
added and the reaction stirred under an atmosphere of ethylene for 40 h at r.t. The crude product was 
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washed with NaOH (3 x 20 ml, 1 M aq.) and the combined organics dried (MgSO4), concentrated under 
reduced pressure and puri purified by flash chromatography (CH2Cl2:MeOH, 100:0-100:5) to afford 
benzoindolizine 8 as a colourless oil (9 mg, 80%). 
υmax (CHCl3)/cm
-1 2924, 1639, 1452; 1H NMR δ (360 MHz, CDCl3) 7.18-7.16 (3H, m), 7.15-7.10 (1H, 
m), 6.52 (1H, dd, Ј 17.5, 10.9), 5.89-5.77 (2H, m), 5.14 (1H, br d, Ј 10.9), 5.08 (1H, br d, Ј 17.5), 5.03 
(1H, dq, Ј 17.1, 1.5), 4.94 (1H, dq, Ј 11.2, 1.9), 4.08 (1H, d, Ј 14.6), 3.93-3.84 (3H, m), 3.58-3.55 (1H, 
m), 2.96-2.92 (1H, m), 2.20-2.14 (2H, m), 1.87-1.80 (1H, m), 1.72-1.61 (1H, m); 13C NMR δ (90.6 
MHz, CDCl3) 140.3 (C), 139.4 (C), 138.8 (CH), 134.9 (C), 131.0 (CH), 129.0 (CH), 128.1 (CH), 126.8 
(CH), 126.1 (CH), 125.8 (CH), 115.3 (CH2), 114.6 (CH2), 69.4 (CH), 58.3 (CH2), 54.0 (CH2), 41.5 
(CH), 32.4 (CH2), 30.8 (CH2); m/z (EI) 251 ([M]
+, 24%), 222 (5), 208 (14), 184 (9), 129 (27), 125 (22), 
84 (100); HRMS (EI) Found: [M]+, 251.1665. C18H21N requires 251.1669.  
Full characterisation of N-propargyl cyclisation precursor 3 (P = CH2CCH), Boc-phenanthridines 4a-c, 
N-propargyl phenanthridines 5a-c and deprotected phenanthridines 9a-c are included in the supporting 
information. 
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Supporting information 
All non-aqueous reactions were carried out under an atmosphere of nitrogen using flame- or oven-dried 
glassware. Unless otherwise noted, starting materials and reagents were obtained from commercial 
suppliers and were used without further purification. CH2Cl2, was distilled from calcium hydride. Flash 
column chromatography was carried out on Merck Kieselgel 60 (Merck 9385) under positive pressure 
by means of an air line or hand pump. TLC was performed on Merck 60F254 (0.25 mm) glass silica 
plates and visualised by ultraviolet (UV) light and/or KMnO4 stain. IR spectra were measured on a 
Biorad FTS-7 or Perkin-Elmer Paragon 1000 FT-IR spectrometer as thin films unless otherwise stated. 
1H and 13C NMR spectra were recorded on a Bruker AC250 or Bruker DPX360 instrument. J values are 
in Hz. Electrospray (ESI) mass spectra were obtained using a Thermo MAT 900 XP mass spectrometer, 
and fast atom bombardment (FAB) mass spectra were obtained using a Kratos MS50TC mass 
spectrometer both at The University of Edinburgh. High performance liquid chromatography (HPLC) 
was carried out using a Gilson instrument fitted with a refractive index detector, using a microsorb 100-
5 Si column (length 250 mm, id 21.4 mm, particle size 5 µm). All HPLC samples were filtered through 
0.45 μm nylon syringe filters prior to analysis. A standard flow rate of 10.0 ml min-1 was used. All 
solvents used for HPLC were filtered prior to use. 
(2-Bromo-benzyl)-cyclohex-3-enyl-prop-2-ynyl-amine 3 (P = CH2CCH): To a suspension of N-(2-
bromobenzyl)-cyclohex-2-enyl-amine hydrochloride4 (100 mg, 0.33 mmol) in DMF (5 ml) at r.t. was 
added K2CO3 (137 mg, 1.00 mmol) and the reaction stirred for 10 mins. Propargyl bromide (148 µl, 80 
% by w/w. in toluene, 1.66 mmol) was added dropwise and the reaction stirred for 16 h. The reaction was 
diluted with Et2O (20 ml) and washed with NaCl (3 x 20 ml, sat. aq.), and the combined organics were 
dried (MgSO4) and concentrated under reduced pressure. The resultant oil was purified using flash 
chromatography (hexane:EtOAc, 100:15) to afford propargyl amine 3 (P = CH2CCH) as a colourless 
oil (103 mg, 99%). 
υmax (CHCl3)/cm
-1 3299(CC-H), 2931, 1439, 1025; 1H NMR δ (250 MHz, CDCl3) 7.59 (1H, d, Ј 7.6, 
ArH), 7.56 (1H, dd, Ј 7.9, 1.2, ArH), 7.29 (1H, td, Ј 7.4, 1.2, ArH), 7.10 (1H, td, Ј 7.8, 1.4, ArH), 5.89-
5.76 (2H, m, CH=CH), 3.91 (1H, d, Ј 15.0, CHXHYAr), 3.82 (1H, d, Ј 15.0, CHXHYAr), 3.56-3.53 (1H, 
m, CHN), 3.38 (2H, d, Ј 2.4, CH2CCH), 2.23 (1H, t, Ј 2.4, CH), 2.03-1.84 (4H, m, 2xCH2), 1.69-1.44 
(2H, m, CH2); 
13C NMR δ (62.9 MHz, CDCl3) 138.7 (C), 132.5 (CH), 130.6 (CH), 130.4 (CH), 129.7 
(CH), 128.1 (C), 127.1 (CH), 124.2 (C), 81.4 (C), 72.2 (CH), 57.6 (CH), 52.9 (CH2), 39.3 (CH2), 25.2 
(CH2), 24.8 (CH2), 21.2 (CH2); m/z (EI) 305 ([
81BrM]+, 19 %), 303 ([79BrM]+, 19), 277 (64), 275 (65), 251 
(33), 249 (35), 213 (42), 171 (97), 169 (100), 106 (85); HRMS (EI) Found: [79BrM]+, 303.0618. 
C16H18N
79Br requires 303.0617. 
(4aSR,10bSR)-4,4a,6,10b-Tetrahydro-3H-phenanthridine-5-carboxylic acid tert-butyl ester 4a (1,2 
isomer)4: Rt [hexane:EtOAc, 92:8] 17 min; υmax (CHCl3)/cm
-1 3026, 1693 (C=O), 1258, 913, 745;  1H 
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NMR δ (360 MHz, 323 K, CDCl3) 7.30 (1H, d, Ј 7.5, ArH), 7.25-7.17 (2H, m, 2xArH), 7.12 (1H, d, Ј 
7.2, ArH), 6.17-6.13 (1H, m, CHCH=CH), 5.87-5.83 (1H, m, CH=CHCH2), 4.71 (1H, d, Ј 16.5, 
CHXHYAr), 4.41 (1H, br s, NCHCH), 4.39 (1H, d, Ј 16.5, CHXHYAr), 3.57 (1H, br s, NCHCH), 2.31-
2.27 (1H, m, CHAHB), 2.15-2.05 (1H, m, CHAHB), 1.79-1.69 (1H, m, CHCHD), 1.61-1.40 (10H, m, 3 x 
CH3+CHCHD); 
13C NMR δ (90.0 MHz, 323 K, CDCl3) 155.0 (C), 137.8 (C), 132.5 (C), 128.3 (CH), 
128.1 (C), 127.6 (CH), 127.3 (CH), 126.8 (CH), 126.1 (CH), 125.9 (CH), 79.6 (C), 43.5 (CH2), 37.3 
(CH), 28.5 (3xCH3), 25.3 (CH2), 24.2 (CH2); m/z (FAB, THIOG) 284 ([M-H]
+, 44 %), 228 (66), 184 
(49), 130 (25); HRMS (FAB, THIOG) Found: [M-H]+ 284.1643. C18H22NO2 requires 284.1650. 
(4aSR,10bSR)-4,4a,6,10b-Tetrahydro-1H-phenanthridine-5-carboxylic acid tert-butyl ester 4b (Δ2,3 
isomer)4: Rt [hexane:EtOAc, 92:8] 18 min; υmax (CHCl3)/cm
-1 3352, 1699 (C=O), 1392, 1367, 1167;  1H 
NMR δ (250 MHz, CDCl3) 7.24-7.16 (4H, m, 4xArH), 5.70-5.66 (1H, m, CHCH2CH=), 5.45-5.37 (1H, 
m, NCHCH2CH=), 4.68-4.66 (3H, m, CH2Ar+NCHCH2), 3.32-3.18 (1H, m, CHCH2), 2.86 (1H, dd, Ј 
18.0, 4.5, CHAHB), 2.67-2.54 (1H, m, CHAHB), 2.28-2.16 (1H, m, CHCHD), 1.65-1.52 (10H, m, 
3xCH3+CHCHD); 
13C NMR δ (62.9 MHz, CDCl3) 154.8 (C), 136.4 (C), 133.9 (C), 126.6 (CH), 126.4 
(CH), 126.1 (CH), 125.4 (CH), 124.8 (CH), 123.7 (CH), 79.6 (C), 50.3 (CH), 44.6 (CH2), 35.5 (CH), 
28.5 (3xCH3), 26.2 (CH2); m/z (EI) 285 ([M]
+, 2 %), 231 (32), 175 (100), 130 (22); HRMS (EI) Found: 
[M]+ 285.1726. C18H23NO2 requires 285.1723.  
(4aSR,10bSR)-2,4a,6,10b-Tetrahydro-1H-phenanthridine-5-carboxylic acid tert-butyl ester 4c (Δ3,4 
isomer)4: Rt [hexane:EtOAc, 92:8] 16 min; υmax (CHCl3)/cm
-1 3359, 1695 (C=O), 1400, 1367;  1H 
NMR δ (250 MHz, CDCl3) 7.37 (1H, d, Ј 7.5, ArH), 7.26-7.13 (2H, m, 2xArH), 7.07 (1H, d, Ј 7.0, 
ArH), 5.72-5.65 (1H, m, CH2CH=CH), 5.52 (1H, d, Ј 11.0, CH=CHCH), 5.08 (1H, br s, NCH), 4.86 
(1H, d, Ј 17.0, CHXHYAr), 4.24 (1H, d, Ј 17.0, CHXHYAr), 3.30 (1H, br s, CHCH2), 2.45-2.37 (1H, m, 
CHACHB), 2.08-1.94 (1H, m, CHAHB), 1.95-1.81 (2H, m, CH2), 1.50 (9H, s, 3xCH3); 
13C NMR δ (62.9 
MHz, CDCl3) 154.8 (C), 135.1 (C), 133.9 (C), 130.8 (CH), 127.6 (CH), 126.5 (2xCH), 125.8 (CH), 
125.6 (CH), 79.8 (C), 50.0 (CH), 42.6 (CH2), 34.5 (CH), 28.4 (3xCH3), 25.0 (CH2), 20.2 (CH2); m/z (EI) 
285 ([M]+, 2 %), 229 (77), 228 (100), 184 (32), 175 (48); HRMS (EI) Found: [M]+ 285.1720. 
C18H23NO2 requires 285.1723. 
(4aSR,10bSR)-3,4,4a,5,6,10b-Hexahydro-phenanthridine 9a: Flash vacuum pyrolysis of Boc-
protected 1,2 isomer phenanthridine 4a [500 mg, Tf 600 
oC, Ti 140 
oC, P 3.2 x 10-2 Torr, t 0.5 h], 
followed by Kugelrohr distillation (70 oC, 0.7 Torr) afforded amine 9a as a yellow oil (193 mg, 60%). 
υmax (CHCl3)/cm
-1 3274 (NH), 3019, 2920, 1671 (C=C), 1449, 1260 (CN); 1H NMR δ (360 MHz, 
CDCl3) 7.22-7.21 (2H, m, 2xArH), 7.17-7.14 (1H, m, ArH), 7.03 (1H, d, Ј 7.5, ArH), 5.74-5.71 (1H, m, 
CH=CH), 5.66-5.62 (1H, m, CH=CH), 4.12 (1H, d, Ј 16.3, CHXHYAr), 4.04 (1H, d, Ј 16.3, CHXHYAr), 
3.36 (1H, br s, NCHCH), 3.32-3.28 (1H, m, NCHCH), 2.25-2.03 (2H, m, CH2), 2.03-1.89 (2H, m, 
CH2); 
13C NMR δ (90.6 MHz, CDCl3) 138.4 (C), 135.7 (C), 130.2 (CH), 129.1 (CH), 126.4 (CH), 125.8 
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(CH), 125.7 (2xCH), 50.4 (CH), 48.3 (CH2), 38.0 (CH), 27.4 (CH2), 20.0 (CH2); m/z (EI) 185 ([M]
+, 77 
%), 170 (21), 168 (18), 131 (38), 130 (72), 128 (46); HRMS (EI) Found: [M]+, 185.1196. C13H15N 
requires 185.1199. 
(4aSR,10bSR)-1,4,4a,5,6,10b-Hexahydro-phenanthridine 9b: Flash vacuum pyrolysis of Boc-
protected 2,3 isomer phenanthridine 4b [900 mg, Tf 600 
oC, Ti 140 
oC, P 3.2 x 10-2 Torr, t 0.5 h], 
followed by Kugelrohr distillation (70 oC, 0.7 Torr) afforded amine 9b as a yellow oil (500 mg, 81%). 
υmax (CHCl3)/cm
-1 3284 (NH), 3021, 2902, 1654 (C=C), 1453, 1260 (CN); 1H NMR δ (360 MHz, 
CDCl3) 7.17-7.13 (2H, m, 2xArH), 7.09-7.02 (2H, m, ArH), 5.73-5.66 (2H, m, CH=CH), 4.24 (1H, d, Ј 
16.5, CHXHYAr), 4.15 (1H, d, Ј 16.5, CHXHYAr), 3.23 (1H, br d, Ј 4.0, NCHCH), 2.81 (1H, ddd, Ј 10.1, 
6.4, 2.7, NCHCH), 2.65-2.59 (1H, m, CHAHB), 2.34-2.28 (1H, m, CHAHB), 2.15-2.10 (2H, m, CH2); 
13C 
NMR δ (90.6 MHz, CDCl3) 141.0 (C), 134.2 (C), 128.2 (CH), 126.0 (CH), 125.9 (CH), 125.8 (CH), 
124.7 (CH), 124.1 (CH), 49.9 (CH), 48.5 (CH2), 35.3 (CH), 31.9 (CH2), 30.1 (CH2); m/z (EI) 185 ([M]
+, 
10 %), 130 (100); HRMS (EI) Found: [M]+, 185.1202. C13H15N requires 185.1199. 
(4aSR,10bSR)-1,2,4a,5,6,10b-Hexahydro-phenanthridine 9c: Flash vacuum pyrolysis of Boc-
protected 3,4 isomer phenanthridine 4c [320 mg, Tf 600 
oC, Ti 140 
oC, P 3.2 x 10-2 Torr, t 0.5 h], 
followed by Kugelrohr distillation (70 oC, 0.7 Torr) gave amine 9c as a yellow oil (190 mg, 71%). 
υmax (CHCl3)/cm
-1 3283 (NH), 3020, 2902, 1654 (C=C), 1453, 1260 (CN); 1H NMR δ (360 MHz, 
CDCl3) 7.23-7.13 (3H, m, 3xArH), 7.03 (1H, d, Ј 7.2, ArH), 5.96-5.85 (2H, m, CH=CH), 4.05 (1H, d, Ј 
16.6, CHXHYAr), 4.00 (1H, d, Ј 16.9, CHXHYAr), 3.46 (1H, br s, NCHCH), 2.74 (1H, dt, Ј 12.6, 3.6, 
NCHCH), 2.22-1.62 (4H, m, 2xCH2); 
13C NMR δ (90.6 MHz, CDCl3) 139.3 (C), 135.8 (C), 130.0 (CH), 
129.2 (CH), 128.3 (CH), 126.1 (CH), 125.7 (CH), 125.5 (CH), 50.7 (CH), 48.2 (CH2), 36.5 (CH), 27.5 
(CH2), 25.8 (CH2); m/z (EI) 185 ([M]
+, 10 %), 130 (100); HRMS (EI) Found: [M]+, 185.1202. C13H15N 
requires 185.1199. 
(4aSR,10bSR)-5-(Prop-2’-ynyl)-3,4,4a,5,6,10b-hexahydro-phenanthridine 5ª: To a solution of amine 
9a (150 mg, 0.81 mmol) in acetone (5 ml) was added K2CO3 (368 mg, 2.67 mmol), and propargyl 
bromide (100 µl, 80 % w/w in toluene, 0.89 mmol). The reaction was heated at 60 
oC for 2 h and then 
concentrated under reduced pressure. Flash chromatography (CH2Cl2) afforded propargyl amine 5a as a 
yellow oil (103 mg, 57%). 
υmax (CHCl3)/cm
-1 3290 (CC-H), 2925, 1696; 1H NMR δ (250 MHz, CDCl3) 7.27-7.10 (3H, m, 
3xArH), 7.10 (1H, d, Ј 7.2, ArH), 5.79 (2H, s, CH=CH), 4.01 (1H, d, Ј 15.0, CHXHYAr), 3.83 (1H, dd, Ј 
17.4, 2.4, CHPHQCCH), 3.81 (1H, d, Ј 15.0, CHXHYAr), 3.56 (1H, dd, Ј 17.4, 2.4, CHPHQCCH), 3.56 
(1H, br s, NCHCH), 3.16 (1H, br s, NCHCH), 2.28 (1H, t, Ј 2.4, CH), 2.14-2.00 (3H, m, 
CH2+CHAHB), 1.87-1.75 (1H, m, CHAHB); 
13C NMR δ (62.9 MHz, CDCl3) 137.3 (C), 133.8 (C), 129.8 
(CH), 128.0 (CH), 126.5 (CH), 126.4 (CH), 126.1 (CH), 125.6 (CH), 78.3 (C), 73.4 (CH), 53.8 (CH), 
Page 12 of 13 
53.4 (CH2), 42.3 (CH2), 39.2 (CH), 23.2 (CH2), 21.9 (CH2); m/z (EI) 223 ([M]
+, 59 %), 222 (100), 208 
(16), 184 (17), 168 (36), 140 (34); HRMS (EI) Found: [M]+, 223.1354. C16H17N requires 223.1356. 
(4aSR,10bSR)-5-(Prop-2’-ynyl)-1,4,4a,5,6,10b-hexahydro-phenanthridine 5b: To a solution of 
amine 9b (50 mg, 0.27 mmol) in acetone (2 ml) was added K2CO3 (112 mg, 0.81 mmol) and propargyl 
bromide (33 µl, 80 % w/w in toluene, 0.30 mmol). The reaction was heated at 60 
oC for 2 h and then 
concentrated under reduced pressure. Flash chromatography (CH2Cl2) afforded propargyl amine 5b as a 
colourless oil (45 mg, 75%). 
υmax (CHCl3)/cm
-1 3292 (CC-H), 2925, 1663, 1604, 1430; 1H NMR δ (360 MHz, CDCl3) 7.17-7.14 
(2H, m, 2xArH), 7.12-7.08 (2H, m, 2xArH), 5.76-5.72 (1H, m, CH=CH), 5.67-5.63 (1H, m, CH=CH), 
4.10 (1H, d, Ј 15.2, CHXHYAr), 3.88 (1H, d, Ј 15.2, CHXHYAr), 3.75 (1H, dd, Ј 15.3, 2.3, 
CHPHQCCH), 3.49 (1H, dd, Ј 15.3, 2.3, CHPHQCCH), 3.08-3.05 (1H, m, NCHCH), 2.99 (1H, td, Ј 
7.9, 2.4, NCHCH), 2.53-2.43 (1H, m, CHAHB), 2.38-2.13 (3H, m, CH2+CHAHB), 2.26 (1H, t, Ј 2.3, 
CH); 13C NMR δ (90.6 MHz, CDCl3) 140.2 (C), 134.0 (C), 127.0 (CH), 126.5 (CH), 126.3 (CH), 
125.8 (CH), 125.7 (CH), 122.9 (CH), 78.3 (C), 73.4 (CH), 54.4 (CH2), 53.3 (CH), 42.2 (CH2), 37.6 
(CH), 31.4 (CH2), 26.4 (CH2); m/z (EI) 223 ([M]
+, 6 %), 222 (6), 168 (100), 129 (25); HRMS (EI) 
Found: [M]+, 223.1350. C16H17N requires 223.1356. 
 
(4aSR,10bSR)-5-(Prop-2’-ynyl)-1,2,4a,5,6,10b-hexahydro-phenanthridine 5c: To a solution of 
amine 9c (52 mg, 0.28 mmol) in acetone (5 ml) was added K2CO3 (116 mg, 0.84 mmol) and propargyl 
bromide (35 µl, 80% w/w in toluene, 0.31 mmol). The reaction was heated at 60 
oC for 2 h and then 
concentrated under reduced pressure. Flash chromatography (CH2Cl2) afforded propargyl amine 5c as a 
yellow oil (37 mg, 60%). 
υmax (CHCl3)/cm
-1 3291 (CC-H), 3027, 2925, 1663; 1H NMR δ (360 MHz, CDCl3) 7.20-7.04 (3H, m, 
3xArH), 7.05 (1H, d, Ј 7.3, 2xArH), 6.02-5.93 (2H, m, CH=CH), 3.98 (1H, d, Ј 15.1, CHXHYAr), 3.82 
(1H, dd, Ј 17.2, 2.3, CHPHQCCH), 3.78 (1H, d, Ј 15.1, CHXHYAr), 3.51 (1H, dd, Ј 17.2, 2.4, 
CHPHQCCH), 3.26 (1H, br s, NCHCH), 2.84 (1H, dt, Ј 11.2, 3.5, NCHCH), 2.27 (1H, t, Ј 2.3, CH), 
2.16-2.04 (3H, m, CH2+CHAHB), 1.85-1.76 (1H, m, CHAHB); 
13C NMR δ (90.6 MHz, CDCl3) 138.8 
(C), 134.5 (C), 132.1 (CH), 128.2 (CH), 126.2 (CH), 126.0 (CH), 125.6 (CH), 125.5 (CH), 78.5 (C), 
73.1 (CH), 54.0 (CH2), 54.0 (CH), 42.3 (CH2), 38.0 (CH), 27.7 (CH2), 25.7 (CH2); m/z (EI) 223 ([M]
+, 
30 %), 222 (47), 194 (10), 169 (100), 129 (15). 
